Cargando…

Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer

Oncolytic viruses have the potential to induce immunogenic cell death (ICD) that may provoke potent and long-lasting anti-cancer immunity. Here we aimed to characterize the ICD-inducing ability of wild-type Adenovirus (Ad), Semliki Forest virus (SFV) and Vaccinia virus (VV). We did so by investigati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jing, Ramachandran, Mohanraj, Jin, Chuan, Quijano-Rubio, Clara, Martikainen, Miika, Yu, Di, Essand, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976683/ https://www.ncbi.nlm.nih.gov/pubmed/31969562 http://dx.doi.org/10.1038/s41419-020-2236-3

Ejemplares similares

Virus-Based Immunotherapy of Glioblastoma
por: Martikainen, Miika, et al.
Publicado: (2019)

IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
por: Martikainen, Miika, et al.
Publicado: (2021)

Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
por: Sarén, Tina, et al.
Publicado: (2017)

An Infection-enhanced Oncolytic Adenovirus Secreting H. pylori Neutrophil-activating Protein with Therapeutic Effects on Neuroendocrine Tumors
por: Ramachandran, Mohanraj, et al.
Publicado: (2013)

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy
por: Deng, Siyuan, et al.
Publicado: (2021)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice
por: Martikainen, Miika, et al.
Publicado: (2017)

CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
por: Jin, Chuan, et al.
Publicado: (2022)

Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
por: Ma, Jing, et al.
Publicado: (2021)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Ixovex-1, a novel oncolytic E1B-mutated adenovirus
por: Anwar, Mohiemen, et al.
Publicado: (2022)

Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
por: Fotaki, Grammatiki, et al.
Publicado: (2017)

Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer
por: Jin, Chuan, et al.
Publicado: (2016)

Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)

Oncolytic Viruses: Priming Time for Cancer Immunotherapy
por: Russell, Luke, et al.
Publicado: (2019)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Rahman, Masmudur M., et al.
Publicado: (2021)

The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy
por: Zolaly, Mohammed A, et al.
Publicado: (2023)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies
por: Jhawar, Sachin R., et al.
Publicado: (2017)

Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
por: Tian, Yaomei, et al.
Publicado: (2022)

Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy
por: Omole, Richard Kolade, et al.
Publicado: (2022)

Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
por: Muthukutty, Palaniyandi, et al.
Publicado: (2023)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
por: Guo, Zong Sheng, et al.
Publicado: (2019)

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
por: Wu, Yi-Ying, et al.
Publicado: (2023)

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
por: Hamid, Omid, et al.
Publicado: (2017)

Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
por: Hoare, Joseph, et al.
Publicado: (2018)

The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy
por: Minott, Jessica A., et al.
Publicado: (2022)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Perspectives on immunotherapy via oncolytic viruses
por: Reale, Alberto, et al.
Publicado: (2019)

Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer
por: Vaccaro, Alessandra, et al.
Publicado: (2023)

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
por: Mardi, Amirhossein, et al.
Publicado: (2022)

From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses
por: Kabiljo, Julijan, et al.
Publicado: (2020)

The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
por: Di Somma, Sarah, et al.
Publicado: (2019)

Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
por: Hillerdal, Victoria, et al.
Publicado: (2014)

Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus
por: Annels, Nicola E., et al.
Publicado: (2018)

Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy
por: Simovic, Boris, et al.
Publicado: (2015)

Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy
por: Liu, Weilin, et al.
Publicado: (2022)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4vf7b1geit3ti9gip4egs43h85